Immunopathogenesis of Pediatric Localized Scleroderma
- PMID: 31114575
- PMCID: PMC6503092
- DOI: 10.3389/fimmu.2019.00908
Immunopathogenesis of Pediatric Localized Scleroderma
Abstract
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibrosis of the skin that, especially in the pediatric population, also affects extracutaneous tissues ranging from muscle to the central nervous system. Although developmental origins have been hypothesized, evidence points to LS as a systemic autoimmune disorder, as there is a strong correlation to family history of autoimmune disease, the presence of shared HLA types with rheumatoid arthritis, high frequency of auto-antibodies, and elevated circulating chemokines and cytokines associated with T-helper cell, IFNγ, and other inflammatory pathways. This inflammatory phenotype of the peripheral blood is reflected in the skin via microarray, RNA Sequencing and tissue staining. Research is underway to identify the key players in the pathogenesis of LS, but close approximation of inflammatory lymphocytic and macrophage infiltrate with collagen and fibroblasts deposition supports the notion that LS is a disease of inflammatory driven fibrosis. The immune system is dynamic and undergoes changes during childhood, and we speculate on how the unique features of the immune system in childhood could potentially contribute to some of the differences in LS between children and adults. Interestingly, the immune phenotype in pediatric LS resembles to some extent the healthy adult cellular phenotype, possibly supporting accelerated maturation of the immune system in LS. We discuss future directions in better understanding the pathophysiology of and how to better treat pediatric LS.
Keywords: autoimmune disease; disease etiology; fibrosis; immunophenotype; localized scleroderma; morphea; pediatric rheumatology; skin.
Figures


Similar articles
-
Cytokine profiles in localized scleroderma and relationship to clinical features.Cytokine. 2011 Aug;55(2):157-64. doi: 10.1016/j.cyto.2011.04.001. Epub 2011 May 4. Cytokine. 2011. PMID: 21536453 Free PMC article. Review.
-
Transcriptomic Evaluation of Juvenile Localized Scleroderma Skin With Histologic and Clinical Correlation.Arthritis Rheumatol. 2021 Oct;73(10):1921-1930. doi: 10.1002/art.41758. Epub 2021 Aug 31. Arthritis Rheumatol. 2021. PMID: 33844442
-
Characterization of Endothelial Cell Subclusters in Localized Scleroderma Skin with Single-Cell RNA Sequencing Identifies NOTCH Signaling Pathway.Int J Mol Sci. 2024 Sep 28;25(19):10473. doi: 10.3390/ijms251910473. Int J Mol Sci. 2024. PMID: 39408800 Free PMC article.
-
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.Semin Arthritis Rheum. 2015 Dec;45(3):284-93. doi: 10.1016/j.semarthrit.2015.06.006. Epub 2015 Jun 17. Semin Arthritis Rheum. 2015. PMID: 26254121 Free PMC article.
-
Autoantibodies in Morphea: An Update.Front Immunol. 2019 Jul 9;10:1487. doi: 10.3389/fimmu.2019.01487. eCollection 2019. Front Immunol. 2019. PMID: 31354701 Free PMC article. Review.
Cited by
-
Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin.Front Pediatr. 2021 Jun 7;9:669116. doi: 10.3389/fped.2021.669116. eCollection 2021. Front Pediatr. 2021. PMID: 34164359 Free PMC article.
-
DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma.Clin Immunol. 2021 Jul;228:108756. doi: 10.1016/j.clim.2021.108756. Epub 2021 May 13. Clin Immunol. 2021. PMID: 33992755 Free PMC article.
-
Morphea: The 2023 update.Front Med (Lausanne). 2023 Feb 13;10:1108623. doi: 10.3389/fmed.2023.1108623. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36860340 Free PMC article. Review.
-
The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo.Biomedicines. 2021 Oct 26;9(11):1545. doi: 10.3390/biomedicines9111545. Biomedicines. 2021. PMID: 34829774 Free PMC article.
-
Case Report: Pansclerotic Morphea-Clinical Features, Differential Diagnoses and Modern Treatment Concepts.Front Immunol. 2021 Mar 9;12:656407. doi: 10.3389/fimmu.2021.656407. eCollection 2021. Front Immunol. 2021. PMID: 33767715 Free PMC article.
References
-
- Peterson L, Nelson A, Su W, Mason T, O'Fallon W, Gabriel S. The epidemiology of morphea (localized scleroderma) in Olmstead County 1960–1993. J Rheumatol. (1997) 24:73–80. - PubMed
-
- Scalapino K, Arkaschaisri T, Lucas M, Fertig N, Helfrich D, Londino AJ, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. (2006) 33:1004–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials